Today: 30 April 2026
Browse Category

NASDAQ:ISRG 22 June 2025 - 7 December 2025

Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical (ISRG) Stock on December 7, 2025: Earnings Beat, Da Vinci 5 Momentum and What Wall Street Expects Next

Intuitive Surgical shares closed at $575.34 on December 5, up 1.18%, near the top of their 52-week range. CalPERS raised its stake by 7% in Q2, while Executive Chair Gary Guthart sold $13 million in stock on December 1. Trading volume was light, but ISRG outperformed medtech peers. Some analysts describe the stock’s technical outlook as neutral.
7 December 2025
·
Intuitive Surgical (ISRG) Stock in December 2025: Earnings Beat, Tariff Risks and New Robotic Rivals

Intuitive Surgical (ISRG) Stock in December 2025: Earnings Beat, Tariff Risks and New Robotic Rivals

Intuitive Surgical shares closed at $575.34 on December 5, up 1.18%, with a market cap near $204 billion. Q3 2025 revenue rose 23% to $2.51 billion and net income climbed 25% to $704 million, driven by double-digit growth in da Vinci and Ion procedures. The company raised its full-year procedure growth outlook. Management warned of margin pressure from tariffs and new competition from Medtronic.
6 December 2025
·
Intuitive Surgical (ISRG) Stock on December 2, 2025: Da Vinci 5 Momentum, Insider Sale and 2026 Wall Street Forecasts

Intuitive Surgical (ISRG) Stock on December 2, 2025: Da Vinci 5 Momentum, Insider Sale and 2026 Wall Street Forecasts

Intuitive Surgical shares closed at $567.37 on December 1, down 1.07% but up 7.34% over the past month, with a market cap near $204 billion. Q3 2025 revenue rose 23% to $2.51 billion, beating forecasts, and non-GAAP EPS jumped 30% to $2.40. Institutional ownership remains above 80%. The company placed 427 da Vinci systems in Q3, including 240 of the new da Vinci 5 model.
3 December 2025
·
Intuitive Surgical (ISRG) Stock Forecast for December 1, 2025: Price, News and Analysis Before the Bell

Intuitive Surgical (ISRG) Stock Forecast for December 1, 2025: Price, News and Analysis Before the Bell

Intuitive Surgical closed at $573.48 on November 28, 2025, up 8% for the month and 21% over three months. Shares sit near the top of a $430–$610 52-week range after strong Q3 results and heavy institutional buying. Market cap stands near $204 billion. Analyst targets cluster in the high $500s to low $600s, with most ratings at “Buy” or “Moderate Buy.”
30 November 2025
·
Intuitive Surgical (ISRG) Stock on November 30, 2025: Fresh News, Big Earnings Beat, and What It Means for Investors

Intuitive Surgical (ISRG) Stock on November 30, 2025: Fresh News, Big Earnings Beat, and What It Means for Investors

Intuitive Surgical shares closed at $573.48 on November 28, 2025, giving the company a market cap near $203.6 billion. Institutional investors hold about 89% of the float, with recent filings showing modest increases from firms like Grantham Mayo and Schroder. The stock is up roughly 30% from October lows after strong earnings, but has underperformed the Nasdaq Composite in some November periods. Analyst consensus remains “Moderate Buy.”
30 November 2025
··
Intuitive Surgical Stock Rockets 17% After Blowout Q3 Earnings – Is $600 Next?

Intuitive Surgical Stock Rockets 17% After Blowout Q3 Earnings – Is $600 Next?

Intuitive reported Q3 revenue of $2.51 billion, up 23% year-over-year, and adjusted EPS of $2.40, beating estimates. Global da Vinci surgery volume rose 19%, with 427 new robots placed and consumables sales hitting $1.52 billion. The company raised its 2025 outlook for procedure growth and gross margin. ISRG shares surged 17% after hours, trading in the mid-$500s on Oct. 22.
22 October 2025
··
Robotics and Automation Trends 2025: Industry Breakthroughs and Market Outlook (Updated: June 27th, 2025)

Robotics and Automation Trends 2025: Industry Breakthroughs and Market Outlook (Updated: June 27th, 2025)

New industrial robot installations reached $16.5 billion in 2024, with over 4.28 million robots active in factories worldwide. Asia led 2023 installations, accounting for 70%, and China alone made up 51%. Amazon operated about 800,000 mobile robots in its fulfillment centers by 2024. Global robot density hit 150 per 10,000 manufacturing workers in 2023, with South Korea surpassing 1,000.
28 June 2025
········
Top 100 Robotics and Drone Companies Shaping the Future of Automation (2025)

Top 100 Robotics and Drone Companies Shaping the Future of Automation (2025)

Amazon Robotics operates over 500,000 mobile robots in its fulfillment centers. DJI holds more than 70% of the global drone market with its Phantom and Mavic series. Intuitive Surgical’s da Vinci system has performed over 10 million surgeries with more than 7,500 units installed. Nuro’s R2 and R3 vehicles received a special U.S. permit for driverless delivery in 2020.
22 June 2025
·······
1 2 3

Stock Market Today

  • Needham & Company Raises Alphabet (GOOGL) Price Target to $450, Citing Strong Upside
    April 30, 2026, 8:48 AM EDT. Needham & Company LLC upgraded Alphabet Inc. (NASDAQ: GOOGL) stock target from $400 to $450, reflecting a potential 28.6% gain. The firm reiterates a "buy" rating on the tech giant. Other analysts, including Robert W. Baird and Wedbush, also raised their price targets, indicating broad bullish sentiment. Alphabet's shares opened at $349.94 with a $4.23 trillion market cap. The company posted impressive earnings of $5.11 per share for Q1, beating estimates by $2.47. Revenue topped $109.9 billion, higher than expected. Alphabet maintains a solid return on equity of 35.01% and a net margin of nearly 33%. Insider John L. Hennessy's recent sale of shares was noted but does not appear to impact overall positive analyst outlooks.

Latest article

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

QUALCOMM Incorporated (QCOM) Stock Jumps as AI Data-Center Bet Offsets Weak Forecast

30 April 2026
Qualcomm shares rose 10.3% premarket Thursday after CEO Cristiano Amon said the smartphone market had bottomed and highlighted progress in data-center chips. Fiscal Q2 revenue fell 3% to $10.6 billion, with handset revenue down 13% but automotive up 38%. The Q3 forecast missed Wall Street estimates. Qualcomm expects chip sales to Chinese handset makers to recover after Q3.
Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

Eli Lilly Raises 2026 Forecast as Mounjaro, Zepbound Sales Keep Weight-Loss Boom Alive

30 April 2026
Eli Lilly raised its 2026 revenue forecast by $2 billion after first-quarter sales jumped 56% to $19.8 billion, driven by Mounjaro and Zepbound, which brought in $12.8 billion. Adjusted earnings reached $8.55 per share. The company cited strong demand but noted lower realized prices and competition from Novo Nordisk remain risks. Foundayo, Lilly’s new oral GLP-1 pill, launched in April but was not included in the quarter’s results.
Go toTop